'Stifling' EU Clinical Trial Directive should be reformed, say medical research bodies
This article was originally published in Scrip
Executive Summary
A group of high-profile European medical organisations and charities are calling on the European Union to reform clinical trial regulations, saying the current regulation is stifling medical advances across the continent.
You may also be interested in...
Hoops, hoopla, big ideas and diabetes
Perhaps only a man who inherited an enthusiasm for peptides could, without a trace of irony, cast diabetes drug development as the work of a pastry chef. But for David Solomon, the son of a peptide devotee, mixed metaphors and stretched comparisons are simply the spray thrown up by his unbridled enthusiasm for his chosen trade, that of basketball coach to GLP-1 receptor agonist developer Zealand Pharma.
How Dennis Gillings took a gamble and built a $3.7bn business
"How the hell will Glaxo need you? You've only got a few people, they've got about 50,000!"